XIST and MUC1-C form an auto-regulatory pathway in driving cancer progression.
Keyi WangAtrayee BhattacharyaNaoki HaratakeTatsuaki DaimonAyako NakashojiHiroki OzawaBo PengWei LiDonald W KufePublished in: Cell death & disease (2024)
The long non-coding RNA X-inactive specific transcript (lncRNA XIST) and MUC1 gene are dysregulated in chronic inflammation and cancer; however, there is no known interaction of their functions. The present studies demonstrate that MUC1-C regulates XIST lncRNA levels by suppressing the RBM15/B, WTAP and METTL3/14 components of the m6A methylation complex that associate with XIST A repeats. MUC1-C also suppresses the YTHDF2-CNOT1 deadenylase complex that recognizes m6A sites and contributes to XIST decay with increases in XIST stability and expression. In support of an auto-regulatory pathway, we show that XIST regulates MUC1-C expression by promoting NF-κB-mediated activation of the MUC1 gene. Of significance, MUC1-C and XIST regulate common genes associated with inflammation and stemness, including (i) miR-21 which is upregulated across pan-cancers, and (ii) TDP-43 which associates with the XIST E repeats. Our results further demonstrate that the MUC1-C/XIST pathway (i) is regulated by TDP-43, (ii) drives stemness-associated genes, and (iii) is necessary for self-renewal capacity. These findings indicate that the MUC1-C/XIST auto-regulatory axis is of importance in cancer progression.
Keyphrases
- long non coding rna
- poor prognosis
- papillary thyroid
- oxidative stress
- stem cells
- transcription factor
- epithelial mesenchymal transition
- signaling pathway
- cell proliferation
- squamous cell
- dna methylation
- young adults
- genome wide identification
- binding protein
- inflammatory response
- rna seq
- childhood cancer
- single cell
- toll like receptor
- nuclear factor